Axsome Therapeutics, Inc.
DE ˙ DB ˙ US05464T1043
€ 199,30 ↑9.50 (5.01%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:19X / Axsome Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership476,701 shares
Latest Disclosed Value $ 80,572,042
Morgan Stanley reports 2.95% decrease in ownership of 19X / Axsome Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 476,701 shares of Axsome Therapeutics, Inc. (DE:19X) valued at $66,881,150 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 491,201 shares of Axsome Therapeutics, Inc.. This represents a change in shares of -2.95% during the quarter. The current value of the position is $95,006,509 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM 05464T104 476,701 -14,500 -2.95 80,572 -10.19 0.0049
2026-05-27 2025-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 491,201 81,621 19.93 89,713 80.35 0.0054
2026-02-13 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 491,201 81,621 89,713 0.0054
2026-05-27 2025-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 409,580 -38,339 -8.56 49,744 6.38 0.0030
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 409,580 -38,339 49,744 0.0030
2025-08-15 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 447,919 -9,497 -2.08 46,758 -12.35 0.0030
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 457,416 -119,442 -20.71 53,349 9.30 0.0038
2025-05-15 2024-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 576,858 166,708 40.65 48,808 32.41 0.0034
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 576,858 166,708 48,808 0.0034
2025-05-14 2024-09-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 410,150 88,169 27.38 36,860 42.21 0.0027
2025-02-14 2024-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 410,150 88,169 36,860 0.0027
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 410,150 88,169 36,860 0.0003
2025-05-14 2024-06-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 321,981 -621,902 -65.89 25,919 -65.59 0.0020
2024-10-17 2024-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 321,981 -621,902 25,919 0.0020
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 321,981 -621,902 25,919 0.0020
2024-10-17 2024-03-31 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 943,883 324,504 52.39 75,322 52.79 0.0060
2024-08-16 2024-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 943,883 324,504 75,322 0.0060
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 943,883 324,504 75,322 0.0060
2024-08-16 2023-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 619,379 320,958 107.55 49,296 136.36 0.0043
2024-02-13 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 619,379 320,958 49,296 0.0043
2023-11-15 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 298,421 -24,896 -7.70 20,857 -10.23 0.0021
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 323,317 -124,455 -27.79 23,234 -15.88 0.0023
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM 05464T104 447,772 -29,484 -6.18 27,619 -24.97 0.0030
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 477,256 -122,275 -20.40 36,811 37.60 0.0042
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 599,531 207,545 52.95 26,752 78.19 0.0036
2022-10-27 2022-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 391,986 161,074 69.76 15,013 57.09 0.0019
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM 05464T104 391,986 161,074 15,013 0.0019
2022-10-27 2022-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 230,912 54,016 30.54 9,557 43.03 0.0013
2022-05-13 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 230,912 54,016 9,557 0.0013
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM 05464T104 176,896 -189,073 -51.66 6,682 -44.60 0.0008
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 365,969 48,523 15.29 12,062 -43.67 0.0016
2021-08-23 2021-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 317,446 174,980 122.82 21,414 165.48 0.0028
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 317,446 174,980 21,414 0.0028
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 142,466 93,505 190.98 8,066 102.21 0.0012
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 48,961 6,786 16.09 3,989 32.79 0.0006
2020-11-13 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 42,175 -3,304 -7.26 3,004 -19.70 0.0006
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 45,479 -46,252 -50.42 3,741 -30.68 0.0008
2020-05-26 2020-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 91,731 35,379 62.78 5,397 -7.33 0.0015
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS COM 05464T104 91,731 35,379 5,397 1,463.9977
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM 05464T104 56,352 -35,890 -38.91 5,824 211.94 0.0014
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS COM 05464T104 92,242 71,356 341.65 1,867 247.67 0.0005
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS COM 05464T104 20,886 -69,797 -76.97 537 -58.37 0.0001
2019-05-15 2019-03-31 13F AXSOME THERAPEUTICS COM 05464T104 90,683 84,636 1,399.64 1,290 7,488.24 0.0004
2019-02-14 2018-12-31 13F AXSOME THERAPEUTICS COM 05464T104 6,047 -963 -13.74 17 -29.17 0.0000
2019-04-23 2018-09-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 7,010 -2,000 -22.20 24 -17.24 0.0000
2018-11-20 2018-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 7,010 0 24 0.0000
2018-11-14 2018-09-30 13F AXSOME THERAPEUTICS COM 05464T104 7,010 -2,000 24
2019-04-23 2018-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 9,010 0 0.00 29 31.82 0.0000
2018-08-14 2018-06-30 13F AXSOME THERAPEUTICS COM 05464T104 9,010 0 29
2019-04-23 2018-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 9,010 3,100 52.45 22 -33.33 0.0000
2018-05-14 2018-03-31 13F AXSOME THERAPEUTICS COM 05464T104 9,010 3,100 22
2019-04-23 2017-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 5,910 1,900 47.38 33 50.00 0.0000
2018-02-14 2017-12-31 13F AXSOME THERAPEUTICS COM 05464T104 5,910 1,900 33
2017-11-14 2017-09-30 13F AXSOME THERAPEUTICS COM 05464T104 4,010 -463 -10.35 22 -12.00 0.0000
2017-08-11 2017-06-30 13F AXSOME THERAPEUTICS COM 05464T104 4,473 -12,830 -74.15 25 -62.69 0.0000
2017-05-22 2017-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 17,303 -32,855 -65.50 67 -80.18 0.0000
2017-05-12 2017-03-31 13F AXSOME THERAPEUTICS COM 05464T104 17,303 67
2017-02-22 2016-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 50,158 28,327 129.76 338 96.51 0.0001
2017-02-13 2016-12-31 13F AXSOME THERAPEUTICS COM 05464T104 50,158 338
2016-11-10 2016-09-30 13F AXSOME THERAPEUTICS COM 05464T104 21,831 -37,786 -63.38 172 -61.69 0.0001
2016-08-12 2016-06-30 13F AXSOME THERAPEUTICS COM 05464T104 59,617 39,944 203.04 449 164.12 0.0002
2016-05-12 2016-03-31 13F AXSOME THERAPEUTICS COM 05464T104 19,673 12,803 186.36 170 165.63 0.0001
2016-02-09 2015-12-31 13F AXSOME THERAPEUTICS COM 05464T104 6,870 6,870 64 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.